Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

BUY
$372.0 - $424.34 $19,716 - $22,490
53 Added 9.57%
607 $249,000
Q1 2024

May 03, 2024

BUY
$284.87 - $413.31 $133,319 - $193,429
468 Added 544.19%
554 $223,000
Q4 2023

Jan 11, 2024

BUY
$227.52 - $312.68 $19,566 - $26,890
86 New
86 $26,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.8B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track River Park Advisors, LLC Portfolio

Follow River Park Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of River Park Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on River Park Advisors, LLC with notifications on news.